CAPRELSA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Vandetanib.
| Product ID | 0310-7820_e7eebdc7-a867-4d35-9b5b-2c1829a4e778 |
| NDC | 0310-7820 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CAPRELSA |
| Generic Name | Vandetanib |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-07-25 |
| Marketing End Date | 2020-05-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022405 |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | VANDETANIB |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2011-07-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022405 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-07-25 |
| Marketing End Date | 2020-05-31 |
| Ingredient | Strength |
|---|---|
| VANDETANIB | 100 mg/1 |
| SPL SET ID: | 4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-7820 | CAPRELSA | Vandetanib |
| 0310-7840 | CAPRELSA | Vandetanib |
| 58468-7820 | CAPRELSA | Vandetanib |
| 58468-7840 | CAPRELSA | Vandetanib |
| 58468-7860 | CAPRELSA | Vandetanib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CAPRELSA 85360880 4211262 Live/Registered |
GENZYME CORPORATION 2011-06-30 |
![]() CAPRELSA 78588611 3092679 Live/Registered |
GENZYME CORPORATION 2005-03-16 |